These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 20885081)
41. The role of positron emission tomography imaging of beta-amyloid in patients with Alzheimer's disease. Xiong KL; Yang QW; Gong SG; Zhang WG Nucl Med Commun; 2010 Jan; 31(1):4-11. PubMed ID: 19972633 [TBL] [Abstract][Full Text] [Related]
42. Preliminary evaluation of fluoro-pegylated benzyloxybenzenes for quantification of β-amyloid plaques by positron emission tomography. Yang Y; Fu H; Cui M; Peng C; Liang Z; Dai J; Zhang Z; Lin C; Liu B Eur J Med Chem; 2015 Nov; 104():86-96. PubMed ID: 26435514 [TBL] [Abstract][Full Text] [Related]
43. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
44. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier. André S; Ansciaux E; Saidi E; Larbanoix L; Stanicki D; Nonclercq D; Vander Elst L; Laurent S; Muller RN; Burtea C J Alzheimers Dis; 2017; 60(4):1547-1565. PubMed ID: 29036827 [TBL] [Abstract][Full Text] [Related]
45. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Yang J; Wadghiri YZ; Hoang DM; Tsui W; Sun Y; Chung E; Li Y; Wang A; de Leon M; Wisniewski T Neuroimage; 2011 Apr; 55(4):1600-9. PubMed ID: 21255656 [TBL] [Abstract][Full Text] [Related]
46. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Lee SP; Falangola MF; Nixon RA; Duff K; Helpern JA Magn Reson Med; 2004 Sep; 52(3):538-44. PubMed ID: 15334572 [TBL] [Abstract][Full Text] [Related]
47. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease. Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641 [TBL] [Abstract][Full Text] [Related]
48. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
49. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice. Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055 [TBL] [Abstract][Full Text] [Related]
50. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques. Yang Y; Zhang X; Cui M; Zhang J; Guo Z; Li Y; Zhang X; Dai J; Liu B Sci Rep; 2015 Jul; 5():12084. PubMed ID: 26170205 [TBL] [Abstract][Full Text] [Related]
51. In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease. Kim E; Di Censo D; Baraldo M; Simmons C; Rosa I; Randall K; Ballard C; Dickie BR; Williams SCR; Killick R; Cash D Sci Rep; 2021 Jun; 11(1):12419. PubMed ID: 34127752 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging. Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859 [TBL] [Abstract][Full Text] [Related]
53. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease. Villemagne VL; Rowe CC J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919 [TBL] [Abstract][Full Text] [Related]
54. Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer's disease. Jung SJ; Park SH; Lee EJ; Park JH; Kong YB; Rho JK; Hur MG; Yang SD; Park YD Arch Pharm Res; 2015 Nov; 38(11):1992-8. PubMed ID: 26012373 [TBL] [Abstract][Full Text] [Related]
55. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Jack CR; Garwood M; Wengenack TM; Borowski B; Curran GL; Lin J; Adriany G; Gröhn OH; Grimm R; Poduslo JF Magn Reson Med; 2004 Dec; 52(6):1263-71. PubMed ID: 15562496 [TBL] [Abstract][Full Text] [Related]
56. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
57. Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits. Ronald JA; Chen Y; Bernas L; Kitzler HH; Rogers KA; Hegele RA; Rutt BK Brain; 2009 May; 132(Pt 5):1346-54. PubMed ID: 19293239 [TBL] [Abstract][Full Text] [Related]
58. Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. Klunk WE; Bacskai BJ; Mathis CA; Kajdasz ST; McLellan ME; Frosch MP; Debnath ML; Holt DP; Wang Y; Hyman BT J Neuropathol Exp Neurol; 2002 Sep; 61(9):797-805. PubMed ID: 12230326 [TBL] [Abstract][Full Text] [Related]
59. Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer's disease transgenic mice. Bigot C; Vanhoutte G; Verhoye M; Van der Linden A Neuroimage; 2014 Feb; 87():111-9. PubMed ID: 24188815 [TBL] [Abstract][Full Text] [Related]
60. A History of Senile Plaques: From Alzheimer to Amyloid Imaging. Beach TG J Neuropathol Exp Neurol; 2022 May; 81(6):387-413. PubMed ID: 35595841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]